Prostamax Protocol

Dosing & Research

Last Updated: September 4, 2026

Also known as: Prostate-Specific Peptide, Prostatic Tissue Bioregulator

Chemical Identity

Prostate tissue health, Epithelial cell differentiation, Benign prostatic hyperplasia models, Prostatic aging research

Half-Life

Not Well Characterized

Administration

Oral

Frequency

1–2 Times Daily With Food

How It Works

Synthetic tetrapeptide bioregulator (Khavinson framework) targeting prostate tissue via proposed peptide-DNA interaction with prostate-specific gene promoters in epithelial, stromal, and glandular cells.
Prostate tissue health
Epithelial cell differentiation
Benign prostatic hyperplasia models
Prostatic aging research

Dose

20–40 mg/day

Frequency

1–2 Times Daily With Food

Notes

Typically 10–30 Day Courses Repeated 1–2x Per Year. Part Of Organ-specific Bioregulator System.

Dose: 20–40 mg/day

Frequency: 1–2 Times Daily With Food

Duration: 10–30 Days

Off Period: Not listed

Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.

COA Verified

Third-party COA-verified research peptides with published batch testing.

Source Coming Soon

Purity Tested

US-based research compound supplier with independent purity testing.

Source Coming Soon

Bulk research peptide sourcing with batch-level documentation.

Source Coming Soon

•

Typically 10–30 day courses repeated 1–2x per year.

•

Part of organ-specific bioregulator system.

Loading citations…

0 approved

For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

Be the first to submit research feedback for this peptide.

Approved submissions will appear here as aggregated insights.